# Excision BioTherapeutics Inc — Form D

Excision BioTherapeutics Inc of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-03. The offering totals $10.5M, of which $10.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-03-03
- Form: D
- Accession: 0001847173-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.5M
- Amount sold: $10.5M
- Minimum investment: $1
- Investors: 6
- Date of first sale: 2021-02-16
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-391112

## Issuer

- Name: Excision BioTherapeutics Inc
- CIK: 0001847173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 988 MARKET STREET, SECOND FLOOR, SAN FRANCISCO, CA, 94102
- Phone: (404) 229-1162

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Vasudev Bailey | Director | New Yoprk City, NY |
| William Carson | Director | Oakland, CA |
| Daniel Dornbusch | Director | San Francisco, CA |
| Ashok Krishnamurthi | Director | San Francisco, CA |
| Daniel Dornbusch | Executive Officer | San Francisco, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-02-22](https://search.stillhousedata.com/formd/0001847173-21-000001) | D | $63.8M | $60.7M |

## More

- [CIK 1847173 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1847173&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001847173-21-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.